| Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH) | 06/18 08:42 | globenewswire.com |
| Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics | 06/03 10:45 | investors.com |
| Liquidia Corporation (LQDA) Q1 2024 Earnings Call Transcript | 05/14 11:05 | seekingalpha.com |
| Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA) | 05/14 10:35 | zacks.com |
| Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update | 05/13 17:43 | globenewswire.com |
| Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD | 05/10 08:00 | globenewswire.com |
| Earnings Preview: Liquidia Technologies, Inc. (LQDA) Q1 Earnings Expected to Decline | 04/25 11:06 | zacks.com |
| Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference | 04/02 09:00 | globenewswire.com |
| Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder | 04/01 06:00 | globenewswire.com |
| Liquidia Corporation (LQDA) Q4 2023 Earnings Call Transcript | 03/13 14:40 | seekingalpha.com |